This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

In regard to therapeutic performance and safety characteristics, generic medications are less expensive than their branded counterparts. One of the main factors fueling the demand for generics is the push to lower the rising healthcare expenses. The market entry of various less expensive generic substitutes was made possible by patent expiration. Some of the significant medications whose patents recently expired included Lucentis by Roche, Adasuve by Galen, Perforomist by Mylan, Northera by Lundbeck, and Narcan by Emergent BioSolutions.

Nuclear medicine contract manufacturing also encompasses the development and production of radiopharmaceuticals. Due to recent corporate acquisitions and share offers, interest in the radiopharmaceutical industry has increased. Also, in May 2021, Curium finalized the acquisition of IASON, which aided the firm in growing its service portfolio of life-saving diagnostic solutions and throughout the European market.

What Questions Should You Ask before Buying a Market Research Report?
• How is the pharmaceutical contract manufacturing market evolving?
• What is driving and restraining the pharmaceutical contract manufacturing market?
• How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each pharmaceutical contract manufacturing submarket develop from 2022 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading pharmaceutical contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the pharmaceutical contract manufacturing projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of pharmaceutical contract manufacturing projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the pharmaceutical contract manufacturing market?
• Where is the pharmaceutical contract manufacturing market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the pharmaceutical contract manufacturing market today, and over the next 10 years:
• Our 318-page report provides 143 tables, 184 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the pharmaceutical contract manufacturing market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising pharmaceutical contract manufacturing prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Services
  • Pharmaceutical Manufacturing Services
    • Pharmaceutical API Manufacturing Services
    • Pharmaceutical FDF Manufacturing Services: Parenteral/Injectable Manufacturing Services, Tablet Manufacturing Services, Capsule Manufacturing Services, Oral Liquid Manufacturing Services, Semi-solid Manufacturing Services, Other Formulation Manufacturing Services
  • Drug Development Services
    • Lead Identification & Candidate Optimization
    • Target Identification & Screening
    • Target Validation & Functional Informatics
    • Other Services
  • Biologics Manufacturing Services
    • Biologics API Manufacturing Services
    • Biologics FDF Manufacturing Services

Drug Type
  • Branded
  • Generic

End User
  • Big Pharmaceutical Companies
  • Small & Medium-sized Pharmaceutical Companies
  • Generic Pharmaceutical Companies
  • Other End-users